BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20222047)

  • 21. Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients.
    Thean LF; Loi C; Ho KS; Koh PK; Eu KW; Cheah PY
    Genes Chromosomes Cancer; 2010 Feb; 49(2):99-106. PubMed ID: 19847890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simple and complex genetics of colorectal cancer susceptibility.
    Baglioni S; Genuardi M
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):35-43. PubMed ID: 15264271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
    Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
    Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
    Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficient DNA repair capacity: a predisposing factor and high risk predictive marker in familial colorectal cancer.
    Ankathil R; Jyothish B; Madhavan J; Nair MK
    J Exp Clin Cancer Res; 1999 Mar; 18(1):33-7. PubMed ID: 10374674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.
    Martin ES; Tonon G; Sinha R; Xiao Y; Feng B; Kimmelman AC; Protopopov A; Ivanova E; Brennan C; Montgomery K; Kucherlapati R; Bailey G; Redston M; Chin L; DePinho RA
    Cancer Res; 2007 Nov; 67(22):10736-43. PubMed ID: 18006816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.
    Kim MY; Yim SH; Kwon MS; Kim TM; Shin SH; Kang HM; Lee C; Chung YJ
    Gastroenterology; 2006 Dec; 131(6):1913-24. PubMed ID: 17087931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer.
    Jagmohan-Changur S; Poikonen T; Vilkki S; Launonen V; Wikman F; Orntoft TF; Møller P; Vasen H; Tops C; Kolodner RD; Mecklin JP; Järvinen H; Bevan S; Houlston RS; Aaltonen LA; Fodde R; Wijnen J; Karhu A
    Cancer Res; 2003 Jan; 63(1):154-8. PubMed ID: 12517792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
    Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B
    Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility genetic variants associated with early-onset colorectal cancer.
    Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
    Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient and tumor characteristics may raise clinicians' awareness of familial colorectal cancer: a Norwegian population-based study.
    Tranø G; Wasmuth H; Sjursen W; Vatten L
    Scand J Gastroenterol; 2011 Oct; 46(10):1236-42. PubMed ID: 21679123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer and the CHEK2 1100delC mutation.
    de Jong MM; Nolte IM; Te Meerman GJ; van der Graaf WT; Mulder MJ; van der Steege G; Bruinenberg M; Schaapveld M; Niessen RC; Berends MJ; Sijmons RH; Hofstra RM; de Vries EG; Kleibeuker JH
    Genes Chromosomes Cancer; 2005 Aug; 43(4):377-82. PubMed ID: 15852425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3.
    Yang R; Chen B; Pfütze K; Buch S; Steinke V; Holinski-Feder E; Stöcker S; von Schönfels W; Becker T; Schackert HK; Royer-Pokora B; Kloor M; Schmiegel WH; Büttner R; Engel C; Lascorz Puertolas J; Försti A; Kunkel N; Bugert P; Schreiber S; Krawczak M; Schafmayer C; Propping P; Hampe J; Hemminki K; Burwinkel B
    Carcinogenesis; 2014 Feb; 35(2):315-23. PubMed ID: 24127187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of familial colorectal cancer risk profiles and microsatellite instability status.
    Lubbe SJ; Webb EL; Chandler IP; Houlston RS
    J Clin Oncol; 2009 May; 27(13):2238-44. PubMed ID: 19307499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22.
    Cicek MS; Cunningham JM; Fridley BL; Serie DJ; Bamlet WR; Diergaarde B; Haile RW; Le Marchand L; Krontiris TG; Younghusband HB; Gallinger S; Newcomb PA; Hopper JL; Jenkins MA; Casey G; Schumacher F; Chen Z; DeRycke MS; Templeton AS; Winship I; Green RC; Green JS; Macrae FA; Parry S; Young GP; Young JP; Buchanan D; Thomas DC; Bishop DT; Lindor NM; Thibodeau SN; Potter JD; Goode EL;
    PLoS One; 2012; 7(5):e38175. PubMed ID: 22675446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic copy number of a carcinogenic single nucleotide polymorphism at 8q24 in non-risk allele colorectal cancer associated with insulin growth factor 2 receptor expression.
    Takahashi Y; Mimori K; Yamamoto K; Watanabe M; Tanaka J; Kudo SE; Sugihara K; Hase K; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Mori M
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():95-9. PubMed ID: 22486879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.